Clinical Trial Update: Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

View source ↗

Summary

This is an observational update on ropeginterferon alfa-2b for polycythemia vera; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Ropeginterferon alfa-2b (ropeginterferon alfa-2b)

Snippet

Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | Conditions: Polycythemia Vera | Status: ACTIVE_NOT_RECRUITING